跳至主要内容
临床试验/NCT00380913
NCT00380913已完成4 期

A Multicenter Trial Evaluating the Efficacy of Cesamet™ for the Symptomatic Treatment of Pain in Patients With Diabetic Peripheral Neuropathy

NEMA Research, Inc.8 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2006年9月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
23
试验地点
8
主要终点
The Average Pain Score at target site.

研究概览

简要总结

This study was designed to evaluate the safety and efficacy of Cesamet™ in controlling pain in subjects experiencing pain due to diabetic peripheral neuropathy.

详细描述

The purpose of this study is to determine the safety and efficacy of Cesamet™ in the symptomatic treatment of pain due to diabetic peripheral neuropathy.

This is a phase IV, multi-center, open label outpatient clinical trial evaluating Cesamet™ treatment for control of pain due diabetic peripheral neuropathy. The study has two phases: a Pretreatment Phase and a Treatment Phase.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with diabetic peripheral neuropathic pain
  • Chronic daily pain present for at least 2 months
  • On stable analgesic regimen for one month
  • Baseline pain score greater than 40mm on a visual analog scale

排除标准

  • Hypersensitivity to compounds in study drug or similar drugs
  • Pregnant or lactating females
  • Drug or alcohol abuse
  • Unstable medical condition

结局指标

主要结局

The Average Pain Score at target site.

次要结局

  • The Worst Pain Score at target site.
  • The Pain at Night Score at target site.
  • Quality of Life measures
  • Patient satisfaction with treatment
  • Safety will be assessed through the collection of AEs and vital signs.

研究者

申办方类型
Industry

研究点 (8)

Loading locations...

相似试验